The majority of SCLCs exhibit very high telomerase levels, which are generally associated with the process of malignant transformation. Whether this is also true for SCLC and whether telomerase inhibitors have anti-tumor efficacy in in vivo and in vitro SCLC models also in combination with other targeted drugs will be analyzed in A03 by M. Fischer.